Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on cancer vaccines.

Virginia F Borges1, Donald Kufe, David E Avigan

  • 1Harvard Medical School, Beth Israel Deaconess Medical Center, and Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA.

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD137 in cancer therapy - bench to bedside.

Immunotherapy·2026
Same author

Refining Stratification in Premenopausal Node-Positive HR<sup>+</sup>/HER2<sup>-</sup> Breast Cancer With a Novel AI-Based Test.

Clinical breast cancer·2026
Same author

M1C IS NECESSARY FOR DARAXONRASIB RESISTANCE OF NSCLC KRAS(G12C) MUTANT CELLS.

bioRxiv : the preprint server for biology·2026
Same author

SOX9 and SEMA7A regulate cell plasticity in the postpartum mammary gland with implications for breast cancer.

bioRxiv : the preprint server for biology·2026
Same author

Multidisciplinary clinics in cancer-models, metrics, and meaning: a review.

The oncologist·2026
Same author

Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Cancer vaccines aim to activate the immune system against tumors using tumor antigens. While preclinical studies show promise, clinical trials are ongoing to assess their effectiveness and safety.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Cancer vaccines are being developed to stimulate tumor-specific immunity.
  • Advances in identifying tumor antigens and understanding tumor immunology drive this research.

Purpose of the Study:

  • To review preclinical and clinical experiences with cancer vaccines.
  • To assess the potential of cancer vaccines as a therapeutic strategy.

Main Methods:

  • Utilizing tumor-associated antigens, peptides, genes, and modified whole tumor cells in preclinical models.
  • Employing dendritic cells modified with tumor antigens for enhanced immune presentation.
  • Initiating clinical trials to evaluate toxicity, immunologic response, and clinical impact.

Main Results:

Related Experiment Videos

  • Preclinical studies have yielded promising results, demonstrating the potential of various vaccine strategies.
  • Clinical trials are underway to validate these findings and assess patient outcomes.

Conclusions:

  • Cancer vaccines represent a promising therapeutic avenue with significant potential.
  • Further research is needed to address remaining challenges and optimize clinical strategies for meaningful treatment outcomes.